India AI Summit 2026: Building Trust and Innovation in AI & MedTech

The discussion highlighted the need to ensure trust, safety, and accountability as AI becomes central to India's economic and social transformation. The speakers highlighted the importance of strong AI governance, ethical deployment, data protection, cybersecurity, and risk mitigation frameworks that balance innovation with responsibility.

The session was addressed by Sukhjit Singh, CTO & Technical Director, AT&T Global Network Services India, Shreya Suri, Partner, IndusLaw, Tamoghna Goswami, Head of Policy, ShareChat, Haridas, Founder & Director, DataVal Analytics.

The discussion was moderated by Shaveta Wadhera Jain, Managing Director, Accenture Consulting.

Another session 'Co-Creating the MedTech Frontier: Ecosystem Innovation toward AI Enabled Health for All' was held as part of the Main-Summit: India AI Impact Summit 2026.

The discussion focused on how AI-enabled MedTech is expanding access to care, enabling early and preventive health management, and improving healthcare efficiency and affordability. With India poised to become a major hub for AI-driven MedTech innovation, panelists emphasized the need for a supportive ecosystem to accelerate product development, market translation, and large-scale deployment.

Key themes included AI-ready data systems, digital health infrastructure, global scalability, and collaborative pathways under the MAHA MedTech Mission.

"India is taking steps to create an enabling innovation ecosystem - A key reform towards this is removal of the mandatory 3-year existence requirement for deep-tech startups to obtain R&D recognition by Department of Scientific and Industrial Research (DSIR) under its Industrial Research and Development Promotion Programme. Removing this 3-year blockage, makes it possible for innovators to apply for MedTech grants much earlier in their journey," T Thangaradjou, Scientist F, Anusandhan National Research Foundation (ANRF) said during the session.

"The Government is conscious of the need to balance both innovation and validation. CDSCO is developing new guidelines on AI in healthcare, while ICMR is revising its frameworks to support both innovation and rigorous validation," Taruna Madan Gupta, Scientist G & Head-Development Research Division, Indian Council of Medical Research (ICMR) said during the session.

Gupta added, "This regulatory effort is being complemented by investments in 84 new clinical trial sites, over 30 Centres for Advanced Research for innovation evaluation, and IITs as Centres of Excellence to support AI-based technologies." (ANI

- ANI